ReviewTargeted oncology2025

PROteolysis TArgeting Chimera (PROTAC) Estrogen Receptor Degraders for Treatment of Estrogen Receptor-Positive Advanced Breast Cancer.

Erika P Hamilton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.